Truvestments Capital’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-224
Closed -$2.92K 1065
2025
Q2
$2.92K Hold
224
﹤0.01% 796
2025
Q1
$3.33K Sell
224
-2,495
-92% -$42.9K ﹤0.01% 799
2024
Q4
$49.4K Sell
2,719
-214
-7% -$2.88K 0.01% 371
2024
Q3
$39.4K Buy
+2,933
New +$43.2K 0.01% 391
2024
Q2
Sell
-4,182
Closed -$78.3K 299
2024
Q1
$78.3K Sell
4,182
-8,557
-67% -$171K 0.03% 309
2023
Q4
$288K Buy
12,739
+3,018
+31% +$65.4K 0.13% 173
2023
Q3
$241K Buy
9,721
+2,013
+26% +$50.7K 0.13% 163
2023
Q2
$216K Buy
7,708
+1,653
+27% +$41K 0.11% 174
2023
Q1
$135K Buy
6,055
+2,819
+87% +$73.8K 0.07% 218
2022
Q4
$86K Buy
3,236
+2,544
+368% +$83K 0.05% 261
2022
Q3
$20K Buy
692
+85
+14% +$2.19K 0.01% 341
2022
Q2
$13K Buy
+607
New +$11.4K 0.01% 383

Other funds holding CCRN

Truvestments Capital's CCRN Position: Q3 2025 in Review

Truvestments Capital sold out of Cross Country Healthcare (CCRN) in Q3 2025, closing a stake of 224 shares — an estimated $2.92K sold.

Truvestments Capital first reported a position in CCRN in Q2 2022 and held it in 12 quarters. The position peaked at $288K in Q4 2023. 169 funds tracked by Wall St. Rank hold CCRN as of Q3 2025.

  • Truvestments Capital reported no remaining Cross Country Healthcare position as of Q3 2025 after selling out during the quarter.
  • Truvestments Capital sold 224 Cross Country Healthcare shares in Q3 2025, an estimated $2.92K.
  • Truvestments Capital first reported a position in Cross Country Healthcare in Q2 2022 and held it in 12 quarters.
  • Truvestments Capital's Cross Country Healthcare position peaked at $288K in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2025.

Based on Truvestments Capital's 13F filing for Q3 2025, filed 14 Nov 2025.